R
Rallybio Corp
NASDAQ:RLYB
Rallybio Corp
NASDAQ:RLYB
Price:
8.28
USD
0.36%
Market Closed
Market Cap:
$43.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
R
|
Rallybio Corp
NASDAQ:RLYB
|
US |
|
G
|
Guobang Pharma Ltd
SSE:605507
|
CN |
|
R
|
Red Metal Resources Ltd
CNSX:RMES
|
CA |
|
Pegasus Sewing Machine Mfg Co Ltd
TSE:6262
|
JP |
|
SinterCast AB
STO:SINT
|
SE |
|
A
|
Aether Catalyst Solutions Inc
CNSX:ATHR
|
CA |
|
S
|
Swedish Logistic Property AB
STO:SLP B
|
SE |
|
J
|
JBT Marel Corp
XMUN:JBT
|
US |
|
Aspire Mining Ltd
ASX:AKM
|
AU |
|
H
|
Hitachi Zosen Corp
TSE:7004
|
JP |
|
HBL Power Systems Ltd
NSE:HBLPOWER
|
IN |
|
Befar Group Co Ltd
SSE:601678
|
CN |
|
T
|
Thai Eastern Group Holdings PCL
SET:TEGH
|
TH |
|
G
|
GHP Specialty Care AB
F:2BQ
|
SE |
|
International Personal Finance PLC
LSE:IPF
|
UK |
|
T
|
Talenthouse AG
SIX:THAG
|
CH |
|
F
|
FendX Technologies Inc
OTC:FDXTF
|
CA |
|
M
|
Manoj Vaibhav Gems N Jewellers Ltd
NSE:MVGJL
|
IN |
|
Orient Overseas (International) Ltd
OTC:OROVY
|
HK |
|
Scanpoint Geomatics Ltd
BSE:526544
|
IN |
Multiples-Based Value
The Multiples-Based Value for Rallybio Corp (RLYB) under the Base Case is hidden USD. Compared with the current market price of 8.28 USD, the stock appears hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
RLYB Multiples-Based Value
LOCKED
Multiples Across Competitors
RLYB Competitors Multiples
Rallybio Corp Competitors
Rallybio Corp Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
R
|
Rallybio Corp
NASDAQ:RLYB
|
43.7m USD | 51 | -4.9 | 0.3 | 0.3 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
368.5B USD | 6 | 88 | 14.6 | 20.3 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.7B USD | 5.1 | 24.3 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
173.5B USD | 5.9 | 20.4 | 12.7 | 15.7 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.2B USD | 9.3 | 28.4 | 21.3 | 22.3 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.7B USD | 5.6 | 17.7 | 13.1 | 15 | |
| NL |
|
argenx SE
XBRU:ARGX
|
43.9B EUR | 12.3 | 39.7 | 43 | 43.9 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.2B AUD | 2.9 | 32.4 | 10.9 | 13.8 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
